S3E5 - Australian Chlamydia Guidelines for Exams

Welcome to Season 3 of AMC Clinical Deep Dive!

As Australia’s most reported communicable disease, chlamydia is frequently asymptomatic (85%–90%), making screening protocols a favourite examiner target. This episode breaks down the latest guidelines: prioritising doxycycline (100mg BD for 7 days) over azithromycin, selecting highly sensitive self-collected vaginal swabs over urine, and managing pregnant patients (who require azithromycin and a mandatory 4-week test of cure). We dive into tracing partners back 6 months, implementing Patient-Delivered Partner Therapy (PDPT), and scheduling the mandatory 3-month retest. Deliver a flawless, high-scoring clinical plan today!

#AMCClinicalExam #Chlamydia #OSCE #Doxycycline #Patient-DeliveredPartnerTherapy(PDPT) #TestofCure #IMGAustralia #ASHMGuidelines #SexualHealthHistory #NAAT

Pro Tip: In your OSCE, do not default to Azithromycin for everyone! Doxycycline (100 mg BD for 7 days) is now the first-line recommendation for uncomplicated chlamydia. If your patient is pregnant, remember two non-negotiable rules: first, treat with Azithromycin 1g stat; second, a Test of Cure (TOC) is mandatory and must be done by NAAT no earlier than 4 weeks after treatment is completed to avoid false-positive DNA results. Additionally, discussing Patient-Delivered Partner Therapy (PDPT) for eligible heterosexual partners demonstrates the state-of-the-art public health integration examiners love to reward!

🎧 ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Episodes in ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Season 1⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ (150 clinical scenarios) have been indexed by topic, patient group, discipline, setting, and more to support targeted learning. Use the filters to locate discussions relevant to your study or clinical training.